BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:26 PM
 | 
Mar 29, 2010
 |  BC Extra  |  Clinical News

GenVec ends TNFerade Phase III

GenVec Inc. (NASDAQ:GNVC) discontinued a Phase III trial to treat locally advanced pancreatic cancer after an interim analysis conducted after the 184th death showed that...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >